An internal DHSS minute, referring to Armour's letter to haemophilia centre directors withdrawing batches of Factorate which had not been donor screened, stated that Rorer Health Care Ltd claimed to be in compliance with their product licence and that the matter had not been treated as a product defect.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation